With the rich prior human experiences, we proposed to screen a natural product library which contains 10,000 extracts against representative breast cancer cells and tried to identify compounds that selectively inhibit HER2-positive breast cancer cells. This evidence concerns the gene ERBB2 and breast carcinoma.